Nils Erik Bernhard

Dannemora Mineral AB operates as a mining and exploration company, which engages primarily in mining operations in the Dannemora iron ore mine. It also engages in the exploration activities to increase the iron ore base locally and regionally, and to explore for base and precious metals in several areas in Uppland. The company was founded by Nils Bernhard and Lennart Falk on March 17, 2005 and is headquartered in Danderyd, Sweden.

Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market.

Chemrec AB is a holding company. It develops and implements solutions for the forest industries for production of biosynfuels, renewable power and increased recovery capacity. The firm technology is based on black liquor gasification. Its transforms pulp and paper mills into biorefineries. The company was founded by Nils Bernhard and Lars Stigsson in 1989 and is headquartered in Stockholm, Sweden.